BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 26091447)

  • 1. Combination Therapy of Metformin and Statin May Decrease Hepatocellular Carcinoma Among Diabetic Patients in Asia.
    Chen HH; Lin MC; Muo CH; Yeh SY; Sung FC; Kao CH
    Medicine (Baltimore); 2015 Jun; 94(24):e1013. PubMed ID: 26091447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of statin on hepatocellular carcinoma in patients with type 2 diabetes: A nationwide nested case-control study.
    Kim G; Jang SY; Han E; Lee YH; Park SY; Nam CM; Kang ES
    Int J Cancer; 2017 Feb; 140(4):798-806. PubMed ID: 27861855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Statin use and risk of hepatocellular carcinoma.
    Lai SW; Liao KF; Lai HC; Muo CH; Sung FC; Chen PC
    Eur J Epidemiol; 2013 Jun; 28(6):485-92. PubMed ID: 23681775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metformin and risk of hepatocellular carcinoma in patients with type 2 diabetes.
    Tseng CH
    Liver Int; 2018 Nov; 38(11):2018-2027. PubMed ID: 29956875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metformin and Hepatocellular Carcinoma Risk Reduction in Diabetic Patients with Chronic Hepatitis C: Fact or Fiction?
    Sacco M; Ribaldone DG; Saracco GM
    Viruses; 2023 Dec; 15(12):. PubMed ID: 38140692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Independent and Joint Use of Statins and Metformin by Elderly Patients With Diabetes and Overall Survival Following HCC Diagnosis.
    Antwi SO; Li Z; Mody K; Roberts LR; Patel T
    J Clin Gastroenterol; 2020; 54(5):468-476. PubMed ID: 32271517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metformin in the prevention of hepatocellular carcinoma in diabetic patients: A systematic review.
    Cunha V; Cotrim HP; Rocha R; Carvalho K; Lins-Kusterer L
    Ann Hepatol; 2020; 19(3):232-237. PubMed ID: 31836424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of hepatocellular carcinoma in diabetic patients and risk reduction associated with anti-diabetic therapy: a population-based cohort study.
    Lai SW; Chen PC; Liao KF; Muo CH; Lin CC; Sung FC
    Am J Gastroenterol; 2012 Jan; 107(1):46-52. PubMed ID: 22085817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metformin and reduced risk of hepatocellular carcinoma in diabetic patients with chronic liver disease.
    Donadon V; Balbi M; Mas MD; Casarin P; Zanette G
    Liver Int; 2010 May; 30(5):750-8. PubMed ID: 20331505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metformin does not improve survival in patients with hepatocellular carcinoma.
    Bhat M; Chaiteerakij R; Harmsen WS; Schleck CD; Yang JD; Giama NH; Therneau TM; Gores GJ; Roberts LR
    World J Gastroenterol; 2014 Nov; 20(42):15750-5. PubMed ID: 25400459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Statin use and the risk of hepatocellular carcinoma in patients at high risk: A nationwide nested case-control study.
    Kim G; Jang SY; Nam CM; Kang ES
    J Hepatol; 2018 Mar; 68(3):476-484. PubMed ID: 29107150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of diabetes medications and glycemic control on risk of hepatocellular cancer in patients with nonalcoholic fatty liver disease.
    Kramer JR; Natarajan Y; Dai J; Yu X; Li L; El-Serag HB; Kanwal F
    Hepatology; 2022 Jun; 75(6):1420-1428. PubMed ID: 34779535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diabetes mellitus and metformin in hepatocellular carcinoma.
    Fujita K; Iwama H; Miyoshi H; Tani J; Oura K; Tadokoro T; Sakamoto T; Nomura T; Morishita A; Yoneyama H; Masaki T
    World J Gastroenterol; 2016 Jul; 22(27):6100-13. PubMed ID: 27468203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer risk in HBV patients with statin and metformin use: a population-based cohort study.
    Chen CI; Kuan CF; Fang YA; Liu SH; Liu JC; Wu LL; Chang CJ; Yang HC; Hwang J; Miser JS; Wu SY
    Medicine (Baltimore); 2015 Feb; 94(6):e462. PubMed ID: 25674734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Statin use and risk of hepatocellular carcinoma in a U.S. population.
    McGlynn KA; Divine GW; Sahasrabuddhe VV; Engel LS; VanSlooten A; Wells K; Yood MU; Alford SH
    Cancer Epidemiol; 2014 Oct; 38(5):523-7. PubMed ID: 25113938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simvastatin-ezetimibe combination therapy is associated with a lower rate of major adverse cardiac events in type 2 diabetics than high potency statins alone: A population-based dynamic cohort study.
    Chang SH; Wu LS; Lee CH; Kuo CT; Liu JR; Wen MS; Chen WJ; See LC; Yeh YH
    Int J Cardiol; 2015; 190():20-5. PubMed ID: 25912112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Statin Use is Associated with Decreased Hepatocellular Carcinoma Recurrence in Liver Transplant Patients.
    Cho Y; Kim MS; Nam CM; Kang ES
    Sci Rep; 2019 Feb; 9(1):1467. PubMed ID: 30728421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Statin treatment reduces the risk of hepatocellular carcinoma but not colon cancer-results from a nationwide case-control study in Sweden.
    Björkhem-Bergman L; Backheden M; Söderberg Löfdal K
    Pharmacoepidemiol Drug Saf; 2014 Oct; 23(10):1101-6. PubMed ID: 25074765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-diabetic medications and the risk of hepatocellular cancer: a systematic review and meta-analysis.
    Singh S; Singh PP; Singh AG; Murad MH; Sanchez W
    Am J Gastroenterol; 2013 Jun; 108(6):881-91; quiz 892. PubMed ID: 23381014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metformin modifies disparity in hepatocellular carcinoma incidence in men with type 2 diabetes but without chronic liver diseases.
    Wang CP; Kuhn J; Shah DP; Schmidt S; Lam YF; MacCarthy D; Tenner L; Ramirez AG
    Cancer Med; 2019 Jun; 8(6):3206-3215. PubMed ID: 30993905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.